Annual FCF
-$56.92 M
-$17.60 M-44.77%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual free cash flow is -$56.92 million, with the most recent change of -$17.60 million (-44.77%) on December 31, 2023.
- During the last 3 years, AVTE annual FCF has fallen by -$49.06 million (-624.27%).
- AVTE annual FCF is now -1946.75% below its all-time high of -$2.78 million, reached on December 31, 2019.
Performance
AVTE Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$16.04 M
+$4.39 M+21.48%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly free cash flow is -$16.04 million, with the most recent change of +$4.39 million (+21.48%) on September 30, 2024.
- Over the past year, AVTE quarterly FCF has dropped by -$1.18 million (-7.93%).
- AVTE quarterly FCF is now -1256.13% below its all-time high of -$1.18 million, reached on March 1, 2020.
Performance
AVTE Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$75.01 M
-$400.00 K-0.54%
September 30, 2024
Summary
- As of February 8, 2025, AVTE TTM free cash flow is -$75.01 million, with the most recent change of -$400.00 thousand (-0.54%) on September 30, 2024.
- Over the past year, AVTE TTM FCF has dropped by -$18.09 million (-31.79%).
- AVTE TTM FCF is now -6240.91% below its all-time high of -$1.18 million, reached on March 1, 2020.
Performance
AVTE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AVTE Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.8% | -7.9% | -31.8% |
| 3 y3 years | -624.3% | -7.9% | -31.8% |
| 5 y5 years | -1946.8% | -7.9% | -31.8% |
AVTE Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.4% | at low | -182.0% | +32.2% | -172.0% | at low |
| 5 y | 5-year | -1946.8% | at low | -1256.1% | +32.2% | -6240.9% | at low |
| alltime | all time | -1946.8% | at low | -1256.1% | +32.2% | -6240.9% | at low |
Aerovate Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.04 M(-21.5%) | -$75.01 M(+0.5%) |
| Jun 2024 | - | -$20.43 M(-13.7%) | -$74.61 M(+7.9%) |
| Mar 2024 | - | -$23.67 M(+59.3%) | -$69.15 M(+21.5%) |
| Dec 2023 | -$56.92 M(+44.8%) | -$14.86 M(-5.0%) | -$56.92 M(-0.0%) |
| Sep 2023 | - | -$15.64 M(+4.5%) | -$56.92 M(+11.5%) |
| Jun 2023 | - | -$14.97 M(+30.9%) | -$51.03 M(+13.2%) |
| Mar 2023 | - | -$11.44 M(-23.1%) | -$45.07 M(+14.6%) |
| Dec 2022 | -$39.32 M | -$14.87 M(+52.5%) | -$39.32 M(+4.5%) |
| Sep 2022 | - | -$9.75 M(+8.3%) | -$37.63 M(+9.2%) |
| Jun 2022 | - | -$9.01 M(+58.3%) | -$34.45 M(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5.69 M(-56.8%) | -$29.45 M(+6.8%) |
| Dec 2021 | -$27.58 M(+250.9%) | -$13.18 M(+100.2%) | -$27.58 M(+59.6%) |
| Sep 2021 | - | -$6.58 M(+64.3%) | -$17.29 M(+31.6%) |
| Jun 2021 | - | -$4.00 M(+5.0%) | -$13.14 M(+25.2%) |
| Mar 2021 | - | -$3.81 M(+32.3%) | -$10.49 M(+33.5%) |
| Dec 2020 | -$7.86 M(+182.6%) | -$2.88 M(+18.5%) | -$7.86 M(+58.0%) |
| Sep 2020 | - | -$2.43 M(+79.0%) | -$4.97 M(+95.7%) |
| Jun 2020 | - | -$1.36 M(+14.9%) | -$2.54 M(+114.9%) |
| Mar 2020 | - | -$1.18 M | -$1.18 M |
| Dec 2019 | -$2.78 M | - | - |
FAQ
- What is Aerovate Therapeutics annual free cash flow?
- What is the all time high annual FCF for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual FCF year-on-year change?
- What is Aerovate Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly FCF year-on-year change?
- What is Aerovate Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Aerovate Therapeutics?
- What is Aerovate Therapeutics TTM FCF year-on-year change?
What is Aerovate Therapeutics annual free cash flow?
The current annual FCF of AVTE is -$56.92 M
What is the all time high annual FCF for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual free cash flow is -$2.78 M
What is Aerovate Therapeutics annual FCF year-on-year change?
Over the past year, AVTE annual free cash flow has changed by -$17.60 M (-44.77%)
What is Aerovate Therapeutics quarterly free cash flow?
The current quarterly FCF of AVTE is -$16.04 M
What is the all time high quarterly FCF for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly free cash flow is -$1.18 M
What is Aerovate Therapeutics quarterly FCF year-on-year change?
Over the past year, AVTE quarterly free cash flow has changed by -$1.18 M (-7.93%)
What is Aerovate Therapeutics TTM free cash flow?
The current TTM FCF of AVTE is -$75.01 M
What is the all time high TTM FCF for Aerovate Therapeutics?
Aerovate Therapeutics all-time high TTM free cash flow is -$1.18 M
What is Aerovate Therapeutics TTM FCF year-on-year change?
Over the past year, AVTE TTM free cash flow has changed by -$18.09 M (-31.79%)